Stifel Nicolaus reissued their buy rating on shares of Healthcare Realty Trust Incorporated (NYSE:HR) in a research report released on Friday. They currently have a $34.00 price objective on the real estate investment trust’s stock.

A number of other equities research analysts have also recently issued reports on HR. KeyCorp set a $25.00 price objective on Healthcare Realty Trust and gave the company a sell rating in a research note on Sunday, October 29th. Zacks Investment Research upgraded Healthcare Realty Trust from a sell rating to a hold rating in a research note on Monday, October 30th. Cantor Fitzgerald reiterated a buy rating and set a $38.00 price target on shares of Healthcare Realty Trust in a research report on Tuesday, August 15th. BMO Capital Markets reiterated a buy rating and set a $34.00 price target on shares of Healthcare Realty Trust in a research report on Thursday. Finally, Jefferies Group LLC reiterated a hold rating and set a $34.00 price target (down from $36.00) on shares of Healthcare Realty Trust in a research report on Thursday, August 10th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus price target of $33.43.

Shares of Healthcare Realty Trust (NYSE HR) traded up $0.03 during trading on Friday, reaching $32.39. The company had a trading volume of 512,478 shares, compared to its average volume of 773,851. The firm has a market capitalization of $4,045.19, a P/E ratio of 20.63, a PEG ratio of 5.11 and a beta of 0.32. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.18 and a current ratio of 2.82.

Healthcare Realty Trust (NYSE:HR) last announced its quarterly earnings data on Wednesday, November 1st. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.39 by ($0.01). Healthcare Realty Trust had a net margin of 26.70% and a return on equity of 6.62%. The firm had revenue of $106.95 million during the quarter, compared to the consensus estimate of $108.97 million. During the same quarter in the prior year, the firm posted $0.39 earnings per share. The company’s revenue was up 3.2% on a year-over-year basis. sell-side analysts expect that Healthcare Realty Trust will post 1.58 EPS for the current year.

WARNING: This piece of content was originally published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/healthcare-realty-trust-incorporated-hr-receives-buy-rating-from-stifel-nicolaus/1681238.html.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 30th. Investors of record on Thursday, November 16th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 3.70%. The ex-dividend date of this dividend is Wednesday, November 15th. Healthcare Realty Trust’s dividend payout ratio (DPR) is 123.71%.

In related news, Director John Knox Singleton acquired 3,450 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were bought at an average cost of $31.88 per share, for a total transaction of $109,986.00. Following the completion of the transaction, the director now owns 17,693 shares in the company, valued at $564,052.84. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.85% of the stock is currently owned by corporate insiders.

A number of institutional investors and hedge funds have recently modified their holdings of HR. Russell Investments Group Ltd. boosted its stake in Healthcare Realty Trust by 100.8% in the second quarter. Russell Investments Group Ltd. now owns 1,041,967 shares of the real estate investment trust’s stock worth $35,559,000 after buying an additional 522,959 shares in the last quarter. FMR LLC boosted its stake in Healthcare Realty Trust by 6.4% in the second quarter. FMR LLC now owns 7,274,016 shares of the real estate investment trust’s stock worth $248,408,000 after buying an additional 434,895 shares in the last quarter. Janus Henderson Group PLC purchased a new stake in Healthcare Realty Trust in the second quarter worth approximately $12,297,000. Northern Trust Corp boosted its stake in Healthcare Realty Trust by 8.6% in the second quarter. Northern Trust Corp now owns 3,367,432 shares of the real estate investment trust’s stock worth $114,997,000 after buying an additional 266,749 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its stake in Healthcare Realty Trust by 67.5% in the second quarter. Goldman Sachs Group Inc. now owns 661,865 shares of the real estate investment trust’s stock worth $22,602,000 after buying an additional 266,676 shares in the last quarter. 91.74% of the stock is owned by institutional investors and hedge funds.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust Incorporated is a self-managed and self-administered real estate investment trust. The Company owns, leases, manages, acquires, finances, develops and redevelops real estate properties associated primarily with the delivery of outpatient healthcare services across the United States.

Analyst Recommendations for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.